Our Vision: To accelerate the rate of medical research in order to more rapidly bring treatments to people with diseases for which there are no effective treatments or cures.

Our Mission: To accelerate the discovery of myelin repair treatments to improve the lives of people suffering from multiple sclerosis (MS), and to establish the Accelerated Research Collaboration™ (ARC™) model as a new paradigm for medical research.

After 50 years of research looking for a cure, there is still little known about MS. The Myelin Repair Foundation was formed to leverage recent myelin-related scientific breakthroughs and develop effective myelin repair treatments. Treatments that repair damage are a "band-aid" that will greatly improve the quality of life until a cure can be found.

With its innovative model for medical research, its narrow focus, and its five-year timeline, the Myelin Repair Foundation is on track toward achieving its goal to license at least one myelin repair drug target by 2009.

MRF’s Accelerated Research Collaboration — bringing best-business practices to the world of academic research — is speeding the time to drug discovery by as much as 100%.